Browse By: Country ι Category ι Publisher ι Tag
Home  »  Pharmaceutical

Pharmaceutical Market Research Reports

The global pharmaceutical market is almost a trillion dollar industry. The pharmaceutical market has been playing a very important role in the area of scientific advancement and has contributed significantly to economic growth all across the globe. The global pharmaceutical market consists of a wide range of mid-sized, and big companies, and multinational corporations like biopharmaceutical firms, pharmaceutical companies, virtual pharmas, generic manufacturer
biotechnology firms. The pharmaceutical market also includes various service and ancillary support firms which provide raw materials, undertake contract research projects, contract sales, manufacturing technologies, and regulatory guidance. 


The global pharmaceutical market is witnessing satisfactory growth owing to factors like high incidence of chronic and contagious diseases, and rising life expectancy. Research and development related investments are also taking place in the pharmaceutical market due to rising demand for innovative and better drugs. An emerging segment in the pharmaceutical market is that of biopharmaceuticals which is extensively applied in proteomics, drug discovery, and genomics. 


The highest market share in the global pharmaceutical market is held by the US. It is expected that emerging economies of the Asia Pacific like India and China will report high rates of growth in the forthcoming years. This is because huge pharmaceutical companies these days are outsourcing their R&D projects to these economies for better cost efficiency and to efficiently utilize the scientific labor pool in these economies. 


The growth of the global pharmaceutical market gets affected due to regulatory measures, price pressures, and high demand for innovative drugs, short product lifecycles, and weak drug pipelines. 


Marketresearchreports.biz provides thousands of detailed and exhaustive market research reports on the global pharmaceutical market that add immense value to your vital business strategies and decisions. These reports contain accurate data and facts that enable you to take the right business decision.

More

Pharmaceutical Business Confidence Report Q3 2014
Pharmaceutical Business Confidence Report Q3 2014” is a new report by Kable that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the pharmaceutical industry. This report also examines executive opinion with regards to the current and future state of the economy and its retrospective effect on the industry. It analyzes the likely effect of supplier price changes, sales performance, and staff headcount within the industry over July–September 2014. In addition, it provides an overview of the key priorities, threats, and opportunities for the global pharmaceutical industry over July–September 2014. Key Findings The report features the opinions of pharmaceutical industr
Published Date: Oct 2014
Published By: Kable Market Research

Price: $1950
EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023
EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023SummaryAllergic conjunctivitis is an inflammation of the eye resulting from an allergic reaction to allergy causing substances (external antigens) like pollen, dander, mold, or other substances. In allergic conjunctivitis, the conjunctiva - a layer of tissue which lines the front part of the eyeball (the white part of the eye) and the inside of the eyelids is inflamed secondary to an immune response to external antigens, usually called allergens. Allergic conjunctivitis is one of the most common eye problems encountered in general ophthalmic practices.GlobalData epidemiologists forecast that the total prevalent cases of allergic conjunctivitis in the 6MM will grow by 5.40% over the next decade, from 155,455,174 total pr
Published Date: Oct 2014
Published By: GlobalData

Price: $3995
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014" provides data on the Chemotherapy Induced Peripheral Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chemotherapy Induced Peripheral Neuropathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chemotherapy Induced Pe
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics
The Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the joint venture partnering agreements entered into by the worlds leading healthcare companies.   This new 1st edition, includes:   Trends in joint venture deals Joint venture agreement structure Joint venture contract documents Top joint venture deals by value Most active joint venture dealmakers Comprehensive directory of joint venture deals since 2009   This report provides details of the latest joint venture agreements announced in the pharmaceutical, biotechnology and diagnostic sectors.   The report provides details of joint venture agreements from 2009 to end of August 2014.   The report pr
Published Date: Oct 2014
Published By: Current Partnering

Price: $1995
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - IsraelSummaryGlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Israel. It identifies the key trends in the countrys healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by Global
Published Date: Oct 2014
Published By: GlobalData

Price: $1995
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H2, 2014
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H2, 2014" provides data on the Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mucopolysaccharidosis II (MPS II) (Hunter Syndrome). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Thrombosis Global Clinical Trials Review, H2, 2014
Thrombosis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Thrombosis Global Clinical Trials Review, H2, 2014" provides data on the Thrombosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thrombosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Thrombosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Unstable Angina Global Clinical Trials Review, H2, 2014
Unstable Angina Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Unstable Angina Global Clinical Trials Review, H2, 2014" provides data on the Unstable Angina clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Unstable Angina. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Unstable Angina. This report is built using data and information sourced from proprietary databases, primary and secondary research
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Vascular Calcification Global Clinical Trials Review, H2, 2014
Vascular Calcification Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Vascular Calcification Global Clinical Trials Review, H2, 2014" provides data on the Vascular Calcification clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vascular Calcification. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Vascular Calcification. This report is built using data and information sourced from proprietary databa
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Vasospastic Angina Global Clinical Trials Review, H2, 2014
Vasospastic Angina Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Vasospastic Angina Global Clinical Trials Review, H2, 2014" provides data on the Vasospastic Angina clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vasospastic Angina. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Vasospastic Angina. This report is built using data and information sourced from proprietary databases, primary and sec
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Venous (Vein) Thrombosis Global Clinical Trials Review, H2, 2014
Venous (Vein) Thrombosis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Venous (Vein) Thrombosis Global Clinical Trials Review, H2, 2014" provides data on the Venous (Vein) Thrombosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous (Vein) Thrombosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Venous (Vein) Thrombosis. This report is built using data and information sourced from propriet
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Ventricular Septal Defect Global Clinical Trials Review, H2, 2014
Ventricular Septal Defect Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Ventricular Septal Defect Global Clinical Trials Review, H2, 2014" provides data on the Ventricular Septal Defect clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Septal Defect. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ventricular Septal Defect. This report is built using data and information sourced from pro
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Anca Vasculitis Global Clinical Trials Review, H2, 2014
Anca Vasculitis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Anca Vasculitis Global Clinical Trials Review, H2, 2014" provides data on the Anca Vasculitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anca Vasculitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anca Vasculitis. This report is built using data and information sourced from proprietary databases, primary and secondary research
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Axial Spondyloarthritis Global Clinical Trials Review, H2, 2014
Axial Spondyloarthritis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Axial Spondyloarthritis Global Clinical Trials Review, H2, 2014" provides data on the Axial Spondyloarthritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Axial Spondyloarthritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Axial Spondyloarthritis. This report is built using data and information sourced from proprietary d
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Behcet's Disease Global Clinical Trials Review, H2, 2014
Behcet's Disease Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Behcet's Disease Global Clinical Trials Review, H2, 2014" provides data on the Behcets Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Behcets Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Behcets Disease. This report is built using data and information sourced from proprietary databases, primary and secondary resear
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Birch Pollen Allergy Global Clinical Trials Review, H2, 2014
Birch Pollen Allergy Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Birch Pollen Allergy Global Clinical Trials Review, H2, 2014" provides data on the Birch Pollen Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Birch Pollen Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Birch Pollen Allergy. This report is built using data and information sourced from proprietary databases, prima
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Cat Allergy Global Clinical Trials Review, H2, 2014
Cat Allergy Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Cat Allergy Global Clinical Trials Review, H2, 2014" provides data on the Cat Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cat Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cat Allergy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analys
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Cedar Pollen Allergy Global Clinical Trials Review, H2, 2014
Cedar Pollen Allergy Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Cedar Pollen Allergy Global Clinical Trials Review, H2, 2014" provides data on the Cedar Pollen Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cedar Pollen Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cedar Pollen Allergy. This report is built using data and information sourced from proprietary databases, prima
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Behcet's Disease Global Clinical Trials Review, H2, 2014
Behcet's Disease Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Behcet's Disease Global Clinical Trials Review, H2, 2014" provides data on the Behcets Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Behcets Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Behcets Disease. This report is built using data and information sourced from proprietary databases, primary and secondary resear
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Global and China Water-Based Antioxidant Industry 2014 Market Research Report
The report firstly introduced Water-based antioxidant basic information included Water-based antioxidant definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Water-based antioxidant industry policy and plan, Water-based antioxidant product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Water-based antioxidant capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Water-based antioxidant products customers application capacity market position company contact information et
Published Date: Sep 2014
Published By: QYResearch

Price: $2200
Global N-acetylcysteine Industry 2014 Market Research Report
The report firstly introduced N-acetylcysteine basic information included N-acetylcysteine definition classification application industry chain structure industry overview; Then introduce North America (United States Canada Mexico etc) Europe (Germany France United Kingdom Italy Spain etc) Asia (China Japan India Korea etc) Rest of World (Australia South America Middle East and Africa etc) Key players 2009-2014 N-acetylcysteine Capacity Production Price Cost Gross Production Value Gross Margin etc Data and information. And the report also listed North America Europe Asia Rest of World regional 2009-2014 N-acetylcysteine consumption and different regions trading business and regional import export and location regions consumption, and also listed global total data. Besides supply an
Published Date: Sep 2014
Published By: QYResearch

Price: $3600
Fibrinogen Deficiency (Factor I deficiency) Global Clinical Trials Review, H2, 2014
Fibrinogen Deficiency (Factor I deficiency) Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Fibrinogen Deficiency (Factor I deficiency) Global Clinical Trials Review, H2, 2014" provides data on the Fibrinogen Deficiency (Factor I Deficiency) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fibrinogen Deficiency (Factor I Deficiency). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Fibrinogen Deficien
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2014
Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2014" provides data on the Peripheral Artery Occlusive Disease (PAOD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Peripheral Artery Occlusive Disease (PAOD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Peripheral Artery Occlu
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Pulmonary Valve Stenosis Global Clinical Trials Review, H2, 2014
Pulmonary Valve Stenosis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Pulmonary Valve Stenosis Global Clinical Trials Review, H2, 2014" provides data on the Pulmonary Valve Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pulmonary Valve Stenosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pulmonary Valve Stenosis. This report is built using data and information sourced from propriet
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Refractory Angina Global Clinical Trials Review, H2, 2014
Refractory Angina Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Refractory Angina Global Clinical Trials Review, H2, 2014" provides data on the Refractory Angina clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Refractory Angina. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Refractory Angina. This report is built using data and information sourced from proprietary databases, primary and secondar
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Renal Artery Stenosis Global Clinical Trials Review, H2, 2014
Renal Artery Stenosis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Renal Artery Stenosis Global Clinical Trials Review, H2, 2014" provides data on the Renal Artery Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Artery Stenosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Artery Stenosis. This report is built using data and information sourced from proprietary databases,
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Global Human Albumin Industry 2014 Market Research Report
The report firstly introduced Human Albumin basic information included Human Albumin definition classification application industry chain structure industry overview; Then introduce North America (United States etc) Europe (Germany Switzerland etc) Asia (China Korea etc) Key players 2009-2014 Human Albumin Capacity Production Price Cost Gross Production Value Gross Margin etc Data and information. And the report also listed North America (United States etc) Europe (Germany Switzerland etc) Asia (China Korea etc) 2009-2014 Human Albumin consumption and different regions trading business and regional import export and location regions consumption, and also listed global total data. Besides supply and demand side data by regions, the report also introduced different technology product
Published Date: Sep 2014
Published By: QYResearch

Price: $3600
Stable Angina Global Clinical Trials Review, H2, 2014
Stable Angina Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Stable Angina Global Clinical Trials Review, H2, 2014" provides data on the Stable Angina clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Stable Angina. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Stable Angina. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-ho
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Supraventricular Tachycardia Global Clinical Trials Review, H2, 2014
Supraventricular Tachycardia Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Supraventricular Tachycardia Global Clinical Trials Review, H2, 2014" provides data on the Supraventricular Tachycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Supraventricular Tachycardia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Supraventricular Tachycardia. This report is built using data and information s
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Systolic Hypertension Global Clinical Trials Review, H2, 2014
Systolic Hypertension Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Systolic Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Systolic Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Systolic Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Systolic Hypertension. This report is built using data and information sourced from proprietary databases,
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Telangiectasis Global Clinical Trials Review, H2, 2014
Telangiectasis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Telangiectasis Global Clinical Trials Review, H2, 2014" provides data on the Telangiectasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Telangiectasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Telangiectasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Thrombophlebitis Global Clinical Trials Review, H2, 2014
Thrombophlebitis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Thrombophlebitis Global Clinical Trials Review, H2, 2014" provides data on the Thrombophlebitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thrombophlebitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Thrombophlebitis. This report is built using data and information sourced from proprietary databases, primary and secondary res
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Anxiety Disorders and Depression Treatment Market [Drug Classes: SSRIs, SNRIs, Benzodiazepines, Beta Blockers, TCAs, TeCAs, Atypical Antipsychotics, Anticonvulsants and MAOIs] - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
Anxiety disorders and depression are common psychiatric disorders that affect a large number of people during their lifetime. This study provides the market analysis for the major drug classes used for the treatment of anxiety disorders and depression. The stakeholders of this report include established pharmaceutical companies as well as new entrants who wish to enter the market. The market overview chapter, which has been provided in the study, analyzes the current market dynamics and other trends such as drivers, restraints, opportunities that would govern the present and future circumstances of the anxiety disorder and depression treatment market. Furthermore, Porter’s five forces analysis has been incorporated in this research to provide the competitive status of the anxi
Published Date: Sep 2014
Published By: Transparency Market Research

Price: $4795
Secondary Hyperparathyroidism - Pipeline Review, H2 2014
Secondary Hyperparathyroidism - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Secondary Hyperparathyroidism - Pipeline Review, H2 2014, provides an overview of the Secondary Hyperparathyroidisms therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Secondary Hyperparathyroidism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Secondary Hyperparathyroidism and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs fro
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Vitiligo - Pipeline Review, H2 2014
Vitiligo - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Vitiligo - Pipeline Review, H2 2014, provides an overview of the Vitiligos therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Vitiligo, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vitiligo and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
House Dust Mite Allergy - Pipeline Review, H2 2014
House Dust Mite Allergy - Pipeline Review, H2 2014SummaryGlobal Markets Directs, House Dust Mite Allergy - Pipeline Review, H2 2014, provides an overview of the House Dust Mite Allergys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for House Dust Mite Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for House Dust Mite Allergy and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 2
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Pulmonary Tuberculosis - Pipeline Review, H2 2014
Pulmonary Tuberculosis - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Pulmonary Tuberculosis - Pipeline Review, H2 2014, provides an overview of the Pulmonary Tuberculosiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Pulmonary Tuberculosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pulmonary Tuberculosis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Post Menopausal Osteoporosis - Pipeline Review, H2 2014
Post Menopausal Osteoporosis - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Post Menopausal Osteoporosis - Pipeline Review, H2 2014, provides an overview of the Post Menopausal Osteoporosiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Post Menopausal Osteoporosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Post Menopausal Osteoporosis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from acr
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Hairy Cell Leukemia - Pipeline Review, H2 2014
Hairy Cell Leukemia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Hairy Cell Leukemia - Pipeline Review, H2 2014, provides an overview of the Hairy Cell Leukemias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hairy Cell Leukemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hairy Cell Leukemia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014, provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Refractory Chronic Lymphocytic Leukemia (CLL), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Refractory Chronic Lymphocytic Leukemia (CLL) and special features on late-stage and discon
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Cerebral Palsy - Pipeline Review, H2 2014
Cerebral Palsy - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Cerebral Palsy - Pipeline Review, H2 2014, provides an overview of the Cerebral Palsys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Cerebral Palsy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cerebral Palsy and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014
Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014, provides an overview of the Relapsing Multiple Sclerosis (RMS)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Relapsing Multiple Sclerosis (RMS), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Relapsing Multiple Sclerosis (RMS) and special features on late-stage and discontinued projects.Global Markets Directs report features
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Epidermolysis Bullosa - Pipeline Review, H2 2014
Epidermolysis Bullosa - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Epidermolysis Bullosa - Pipeline Review, H2 2014, provides an overview of the Epidermolysis Bullosas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Epidermolysis Bullosa, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Epidermolysis Bullosa and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Genital Herpes - Pipeline Review, H2 2014
Genital Herpes - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Genital Herpes - Pipeline Review, H2 2014, provides an overview of the Genital Herpess therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Genital Herpes, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Genital Herpes and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Etubics Corporation - Product Pipeline Review - 2014
Etubics Corporation - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Etubics Corporation - Product Pipeline Review - 2014, provides an overview of the Etubics Corporations pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Etubics Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Sutro Biopharma, Inc. - Product Pipeline Review - 2014
Sutro Biopharma, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Sutro Biopharma, Inc. - Product Pipeline Review - 2014, provides an overview of the Sutro Biopharma, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Sutro Biopharma, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 ind
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Philogen S.p.A. - Product Pipeline Review - 2014
Philogen S.p.A. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Philogen S.p.A. - Product Pipeline Review - 2014, provides an overview of the Philogen S.p.A.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Philogen S.p.A.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014
Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014, provides an overview of the Arbor Pharmaceuticals, LLC.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Arbor Pharmaceuticals, LLC.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy ar
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
AUS Bio Limited - Product Pipeline Review - 2014
AUS Bio Limited - Product Pipeline Review - 2014SummaryGlobal Markets Directs, AUS Bio Limited - Product Pipeline Review - 2014, provides an overview of the AUS Bio Limiteds pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of AUS Bio Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
ContraFect Corporation - Product Pipeline Review - 2014
ContraFect Corporation - Product Pipeline Review - 2014SummaryGlobal Markets Directs, ContraFect Corporation - Product Pipeline Review - 2014, provides an overview of the ContraFect Corporations pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of ContraFect Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Five Prime Therapeutics, Inc. - Product Pipeline Review - 2014
Five Prime Therapeutics, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Five Prime Therapeutics, Inc. - Product Pipeline Review - 2014, provides an overview of the Five Prime Therapeutics, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Five Prime Therapeutics, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 th
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
PharmaNova Inc. - Product Pipeline Review - 2014
PharmaNova Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, PharmaNova Inc. - Product Pipeline Review - 2014, provides an overview of the PharmaNova Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of PharmaNova Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Pharis Biotec GmbH - Product Pipeline Review - 2014
Pharis Biotec GmbH - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Pharis Biotec GmbH - Product Pipeline Review - 2014, provides an overview of the Pharis Biotec GmbHs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Pharis Biotec GmbHs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Th
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Selecta Biosciences, Inc. - Product Pipeline Review - 2014
Selecta Biosciences, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Selecta Biosciences, Inc. - Product Pipeline Review - 2014, provides an overview of the Selecta Biosciences, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Selecta Biosciences, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014
Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014, provides an overview of the Pacific Northwest Biotechnology, LLCs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Pacific Northwest Biotechnology, LLCs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from acro
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Alba Therapeutics Corporation - Product Pipeline Review - 2014
Alba Therapeutics Corporation - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Alba Therapeutics Corporation - Product Pipeline Review - 2014, provides an overview of the Alba Therapeutics Corporations pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Alba Therapeutics Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 th
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Aileron Therapeutics, Inc. - Product Pipeline Review - 2014
Aileron Therapeutics, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Aileron Therapeutics, Inc. - Product Pipeline Review - 2014, provides an overview of the Aileron Therapeutics, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Aileron Therapeutics, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Clarassance, Inc. - Product Pipeline Review - 2014
Clarassance, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Clarassance, Inc. - Product Pipeline Review - 2014, provides an overview of the Clarassance, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Clarassance, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The re
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Morvus Technology Ltd - Product Pipeline Review - 2014
Morvus Technology Ltd - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Morvus Technology Ltd - Product Pipeline Review - 2014, provides an overview of the Morvus Technology Ltds pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Morvus Technology Ltds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 ind
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
SBI Biotech Co., Ltd. - Product Pipeline Review - 2014
SBI Biotech Co., Ltd. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, SBI Biotech Co., Ltd. - Product Pipeline Review - 2014, provides an overview of the SBI Biotech Co., Ltd.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of SBI Biotech Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 ind
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Pharma Mar, S.A. - Product Pipeline Review - 2014
Pharma Mar, S.A. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Pharma Mar, S.A. - Product Pipeline Review - 2014, provides an overview of the Pharma Mar, S.A.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Pharma Mar, S.A.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Maruishi Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
Maruishi Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Maruishi Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014, provides an overview of the Maruishi Pharmaceutical Co., Ltd.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Maruishi Pharmaceutical Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe cov
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Melior Discovery, Inc. - Product Pipeline Review - 2014
Melior Discovery, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Melior Discovery, Inc. - Product Pipeline Review - 2014, provides an overview of the Melior Discovery, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Melior Discovery, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Memgen, LLC. - Product Pipeline Review - 2014
Memgen, LLC. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Memgen, LLC. - Product Pipeline Review - 2014, provides an overview of the Memgen, LLC.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Memgen, LLC.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Celentyx Ltd. - Product Pipeline Review - 2014
Celentyx Ltd. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Celentyx Ltd. - Product Pipeline Review - 2014, provides an overview of the Celentyx Ltd.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Celentyx Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built us
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Alios BioPharma, Inc. - Product Pipeline Review - 2014
Alios BioPharma, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Alios BioPharma, Inc. - Product Pipeline Review - 2014, provides an overview of the Alios BioPharma, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Alios BioPharma, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 ind
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
AltraVax Inc. - Product Pipeline Review - 2014
AltraVax Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, AltraVax Inc. - Product Pipeline Review - 2014, provides an overview of the AltraVax Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of AltraVax Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built us
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Hyperemia Global Clinical Trials Review, H2, 2014
Hyperemia Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Hyperemia Global Clinical Trials Review, H2, 2014" provides data on the Hyperemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Glob
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014
Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014" provides data on the Hypertropic Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypertropic Cardiomyopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hypertropic Cardiomyopathy. This report is built using data and information sourced fro
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2014
Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Idiopathic (Essential) Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Idiopathic (Essential) Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Idiopathic (Essential) Hypertension. This report is
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014
Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Idiopathic Pulmonary Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Idiopathic Pulmonary Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Idiopathic Pulmonary Hypertension. This report is built usi
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Intermittent Claudication Global Clinical Trials Review, H2, 2014
Intermittent Claudication Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Intermittent Claudication Global Clinical Trials Review, H2, 2014" provides data on the Intermittent Claudication clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Intermittent Claudication. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Intermittent Claudication. This report is built using data and information sourced from pro
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Ischemia Reperfusion Injury Global Clinical Trials Review, H2, 2014
Ischemia Reperfusion Injury Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Ischemia Reperfusion Injury Global Clinical Trials Review, H2, 2014" provides data on the Ischemia Reperfusion Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ischemia Reperfusion Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ischemia Reperfusion Injury. This report is built using data and information source
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2014
Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2014" provides data on the Ischemic Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ischemic Cardiomyopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ischemic Cardiomyopathy. This report is built using data and information sourced from proprietary d
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2014
Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2014" provides data on the Microscopic Polyangiitis (MPA) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Microscopic Polyangiitis (MPA). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Microscopic Polyangiitis (MPA). This report is built using data and inf
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Myocardial Ischemia Global Clinical Trials Review, H2, 2014
Myocardial Ischemia Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Myocardial Ischemia Global Clinical Trials Review, H2, 2014" provides data on the Myocardial Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myocardial Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myocardial Ischemia. This report is built using data and information sourced from proprietary databases, primary an
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2014
Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2014" provides data on the Occlusive Arterial Disease (OAD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Occlusive Arterial Disease (OAD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Occlusive Arterial Disease (OAD). This report is built using da
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2014
Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2014" provides data on the Occlusive Coronary Artery Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Occlusive Coronary Artery Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Occlusive Coronary Artery Disease. This report is built usi
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Pericarditis Global Clinical Trials Review, H2, 2014
Pericarditis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Pericarditis Global Clinical Trials Review, H2, 2014" provides data on the Pericarditis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pericarditis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pericarditis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house a
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Research Report on China Avian Influenza Vaccine Industry : 2014-2018
Many countries choose to kill all infected poultry to control avian influenza, instead of immunizations. The total number of poultry exceeds 10 billion in China. Epidemic diseases, which are difficult to control, will result in huge losses. Therefore, it is quite necessary to immunize the poultry with avian influenza vaccines.  Avian influenza vaccines have been used for more than 10 years in China. Some poultry farms in China began to use H5N1 avian influenza vaccines voluntarily 10 years ago without compulsory requirements. Chinese avian influenza vaccine industry was in the initial stage in 2001-2005 with upcoming problems. To resolve these problems, the Ministry of Agriculture of China sets up an entry barrier for the avian influenza vaccine production and imposes strict superv
Published Date: Sep 2014
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $1800
Premature Ejaculation - Pipeline Review, H2 2014
Premature Ejaculation - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Premature Ejaculation - Pipeline Review, H2 2014, provides an overview of the Premature Ejaculations therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Premature Ejaculation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Premature Ejaculation and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014
Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014, provides an overview of the Recurrent Head And Neck Cancer Squamous Cell Carcinomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Recurrent Head And Neck Cancer Squamous Cell Carcinoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Recurrent Head And Neck Cancer Squamous Cell Carcinoma
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Arrhythmias - Pipeline Review, H2 2014
Arrhythmias - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Arrhythmias - Pipeline Review, H2 2014, provides an overview of the Arrhythmiass therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Arrhythmias, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Arrhythmias and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Venous Thromboembolism - Pipeline Review, H2 2014
Venous Thromboembolism - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Venous Thromboembolism - Pipeline Review, H2 2014, provides an overview of the Venous Thromboembolisms therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Venous Thromboembolism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Venous Thromboembolism and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2014
Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2014, provides an overview of the Functional (Non Ulcer) Dyspepsias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Functional (Non Ulcer) Dyspepsia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Functional (Non Ulcer) Dyspepsia and special features on late-stage and discontinued projects.Global Markets Directs report features investigat
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Eosinophilic Esophagitis - Pipeline Review, H2 2014
Eosinophilic Esophagitis - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Eosinophilic Esophagitis - Pipeline Review, H2 2014, provides an overview of the Eosinophilic Esophagitiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Eosinophilic Esophagitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Eosinophilic Esophagitis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering o
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Fatty Liver Disease - Pipeline Review, H2 2014
rkets Directs, Fatty Liver Disease - Pipeline Review, H2 2014, provides an overview of the Fatty Liver Diseases therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Fatty Liver Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Fatty Liver Disease and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and i
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2014
Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2014, provides an overview of the Paroxysmal Nocturnal Hemoglobinurias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Paroxysmal Nocturnal Hemoglobinuria, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Paroxysmal Nocturnal Hemoglobinuria and special features on late-stage and discontinued projects.Global Markets Directs report feat
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Bone Regeneration - Pipeline Review, H2 2014
Bone Regeneration - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Bone Regeneration - Pipeline Review, H2 2014, provides an overview of the Bone Regenerations therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Bone Regeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bone Regeneration and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,0
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Metastatic Ovarian Cancer - Pipeline Review, H2 2014
Metastatic Ovarian Cancer - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Metastatic Ovarian Cancer - Pipeline Review, H2 2014, provides an overview of the Metastatic Ovarian Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Metastatic Ovarian Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Ovarian Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe cover
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2014
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2014, provides an overview of the Female Hypoactive Sexual Desire Disorders therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Female Hypoactive Sexual Desire Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Female Hypoactive Sexual Desire Disorder and special features on late-stage and discontinued projects.Global Ma
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Polycystic Ovarian Syndrome - Pipeline Review, H2 2014
Polycystic Ovarian Syndrome - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Polycystic Ovarian Syndrome - Pipeline Review, H2 2014, provides an overview of the Polycystic Ovarian Syndromes therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Polycystic Ovarian Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Polycystic Ovarian Syndrome and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across g
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Heart Attack - Pipeline Review, H2 2014
Heart Attack - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Heart Attack - Pipeline Review, H2 2014, provides an overview of the Heart Attacks therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Heart Attack, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Heart Attack and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The repor
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Keloids - Pipeline Review, H2 2014
Keloids - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Keloids - Pipeline Review, H2 2014, provides an overview of the Keloidss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Keloids, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Keloids and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Eczema - Pipeline Review, H2 2014
Eczema - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Eczema - Pipeline Review, H2 2014, provides an overview of the Eczemas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Eczema, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Eczema and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and info
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Peptic Ulcers - Pipeline Review, H2 2014
Peptic Ulcers - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Peptic Ulcers - Pipeline Review, H2 2014, provides an overview of the Peptic Ulcerss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Peptic Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Peptic Ulcers and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Herpes Zoster (Shingles) - Pipeline Review, H2 2014
Herpes Zoster (Shingles) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Herpes Zoster (Shingles) - Pipeline Review, H2 2014, provides an overview of the Herpes Zoster (Shingles)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Herpes Zoster (Shingles), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Herpes Zoster (Shingles) and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering o
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Influenza B Infections - Pipeline Review, H2 2014
Influenza B Infections - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Influenza B Infections - Pipeline Review, H2 2014, provides an overview of the Influenza B Infectionss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Influenza B Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Influenza B Infections and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Hyperglycemia - Pipeline Review, H2 2014
Hyperglycemia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Hyperglycemia - Pipeline Review, H2 2014, provides an overview of the Hyperglycemias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hyperglycemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hyperglycemia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Anaplastic Thyroid Cancer - Pipeline Review, H2 2014
Anaplastic Thyroid Cancer - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Anaplastic Thyroid Cancer - Pipeline Review, H2 2014, provides an overview of the Anaplastic Thyroid Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Anaplastic Thyroid Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anaplastic Thyroid Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe cover
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000